Tenaya Therapeutics (TNYA) said late Monday it priced an underwritten public offering of 75 million units at $0.70 per unit for gross proceeds of $52.5 million.
Each unit consists of one common share, one warrant to purchase one common share at an exercise price of $0.80 per share, and one warrant to purchase one-half of a common share at an exercise price of $0.70 per share.
Net proceeds will be used to fund clinical development activities, working capital and general corporate purposes, the company said.
Closing of the offering is expected on or about Wednesday, subject to customary conditions.
Tenaya Therapeutics shares fell more than 27% in after-hours activity Monday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。